✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Kimia Biosciences Ltd.

KIMIABL

Market Cap
₹167 Cr.
P/E
17.40

Kimia Biosciences Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
167 Cr
PE
PE
17.40
Prom Holding
Prom Holding
74.94 %
ROE (%)
ROE (%)
96.45
ROCE (%)
ROCE (%)
65.85
Div Yield (%)
Div Yield (%)
-
Sales
Sales
117 Cr
OPM (%)
OPM (%)
14.09 %
Debt to Equity
Debt to Equity
3.27
Institutions
Institutions
0.38 %
Individual < 2 lac
Individual < 2 lac
6.86 %
No. of Shareholders
No. of Shareholders
12,775
View more
Edit Ratio's

About

Laurel Organics Ltd. is a Public limited company, was incorporated in September 1993 in distri… Read more
Low
23
52W Range
High
87
  • Kimia Biosciences
  • Coral Laboratories
  • Panchsheel Organics

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

3 Neutral

Neutral for this company

8 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source

    Peer Comparison

    FAQs on Kimia Biosciences Ltd. Business

    Laurel Organics Ltd. is a Public limited company specializing in the manufacturing of over thirty intermediates for various medical fields including Cardiovascular, Diabetes, and Dermatology.

    Kimia Biosciences major competitors are Panchsheel Organics, Balaxi Pharma., Coral Laboratories, Brooks Laboratories, Alpa Lab, Krebs Biochem.&Inds, Lyka Labs.
    Market Cap of Kimia Biosciences is ₹178 Crs.
    While the median market cap of its peers are ₹155 Crs.

    Kimia Biosciences seems to be less financially stable compared to its competitors.
    Altman Z score of Kimia Biosciences is 2.62 and is ranked 7 out of its 8 competitors.

    View FAQ's On Shareprice

    Company Filing

    2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release
    Investor Presentation
    Conference Call
    Conference Call SummaryCon Call Summary

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material